Rhesus anti-D immunoglobulin in chronic autoimmune neuropathy.
To investigate the effect of Rhesus anti-D immunoglobulin (anti-D) in patients with an autoimmune demyelinating neuropathy. Three patients with an autoimmune mediated neuropathy received 1000 IU anti-D weekly for 2 months. Two patients worsened gradually during the treatment and 1 remained unchanged. Rhesus anti-D immunoglobulin has no beneficial effect in patients with autoimmune neuropathy.